Hypervision Surgical (“Hypervision”) was recently featured at the UK Parliament’s Science, Innovation and Technology Committee, as part of the House of Commons' Innovation Showcase inquiry designed to highlight standout achievements in UK innovation. Hypervision was introduced by Professor Seb Ourselin FREng FMedSci – Co-founder and Non-Executive Director of Hypervision, and Assistant Principal (Innovation) at King’s College London.
Professor Ourselin was invited to present the early successes of St Thomas’ MedTech Hub, a thriving innovation ecosystem that brings together healthcare, academia, and industry. Designed to accelerate the development, translation, and commercialisation of advanced medical technologies, the Hub is home to several pioneering ventures – among them Hypervision, a King’s College London spin-out headquartered at the London Institute for Healthcare Engineering (LIHE).
Professor Seb Ourselin FREng FMedSci presenting HYPERSNAP® at the UK Parliament’s Science, Innovation and Technology Committee – the world’s first certified medical device using hyperspectral imaging (HSI) for real-time surgical guidance, recently cleared for use in both open and minimally invasive general surgery.
Redefining Surgical Visualisation
Hypervision aims to transform the future of surgery with its real-time hyperspectral imaging platform. The company has developed the world’s first certified medical device using hyperspectral imaging for real-time intraoperative guidance.
Combining “superhuman” hyperspectral vision with advanced AI, Hypervision’s technology reveals previously invisible tissue characteristics in real time. This empowers surgeons to make more informed decisions during operations, enhancing precision and improving patient outcomes.
The company’s first product HYPERSNAP®, now certified for use in both open and minimally invasive general surgeries in the UK, delivers continuous, real-time insight into tissue oxygenation. This breakthrough capability has the potential to significantly reduce life-threatening complications such as anastomotic leakage during colorectal procedures, addressing a major unmet need in surgical care.
Innovation Through Collaboration
The development and growth of Hypervision has been deeply supported by the collaborative framework of the St Thomas’ MedTech Hub. By combining cutting-edge academic research, NHS clinical expertise, and commercial know-how, the Hub has created fertile ground for ventures like Hypervision to grow and succeed.
During the Committee session, Professor Ourselin emphasised the importance of continued government and industry support for translational ecosystems like the MedTech Hub and LIHE. These environments not only help UK-led innovations reach the clinic, but also enable them to lead on the global stage.
You can watch the Science, Innovation and Technology Committee meeting here.